Introducing Xanthigen® – a new class of weight management supplement that supports body fat reduction and weight loss

Xanthigen® supports healthy body weight through the synergistic effects of the natural compounds found in Brown Seaweed (Undaria pinnatifida) and Pomegranate Seed Oil.

Separately, the bioactive compounds in these two ingredients target pathways involved in body weight regulation including adipocyte differentiation, resting energy expenditure and lipid metabolism. Combined in Xanthigen® they support weight loss as demonstrated in a recent clinical trial. This study involved a total of 151 obese, non-diabetic females and showed significant weight loss by those taking Xanthigen® versus those taking placebo over the course of the16 weeks trial.


Xanthigen® is a registered trademark exclusively licensed to Nektium, Spain.

Xanthigen® is supported by clinical and pre-clinical research that shows
efficacy in human subjects and provides an understanding of
how Xanthigen® works

Xanthigen® - Clinical Efficacy to Support Healthy Weight †

  • Peer-reviewed, published, double-blind, placebo-controlled clinical trial
  • Study subjects taking 600 mg Xanthigen® daily lost an average of 14.2 pounds (6.6 kg) over sixteen weeks. Significant differences in weight loss vs. placebo began at 6 weeks.
  • Xanthigen® supplementation also resulted in significant body composition improvements  including reduced body and liver fat.
  • Significant improvements in blood lipids, liver enzymes and blood pressure demonstrate better overall health in subjects consuming Xanthgen®.



Reduced Waist Circumference in Subjects
taking Xanthigen

† Abidov M, et.al., The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes Metab. 2010 Jan;12(1):72-81.

Xanthigen® is a registered trademark exclusively licensed to Nektium, Spain.